Skip to Content

BetaShares Global Healthcare ETF (DRUG)

DRUG $9.61

20 minute delayed

Today ▼ -0.62%
1 year return ▲ 17.91%
Volume 24,529
Div yield —
PE ratio —
52 week range
8.10 9.74

14 days free access

Join Market Matters and get full access to all our Opinion + Action

Learn more

Performance

Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.

Share price activity

Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
Last (Price)
9.61
Change
▼ -0.06 (-0.62)
Bid / Ask
9.60 - 9.70
Volume
24,529
Turnover
236,113
Open
9.67
Day Range
9.60 - 9.67
VWAP
9.63
Prev Close
9.67
Last Trade
04/11 3:59pm

Fund profile

Displays who issues the fund, how it is structured and invests, its Morningstar category and benchmark, size, headline costs and dates, sourced from Morningstar. Fund size counts every class of the fund; ETF net assets is this listing alone.

Fund size

$129.9M

OCT 2026

Total cost ratio

0.57%

per year

Distributions

Semi-Annually

Since inception

10.3 yrs

AUG 2016

Legal name
Betashares Global Healthcare Currency Hedged ETF
Issuer
BetaShares Capital Ltd
Type
Exchange-Traded Fund
Structure
Open Ended Investment Company
Management style
Index fund
Morningstar category
Equity World Other
Category index
MSCI World Ex Australia NR AUD
Benchmark
Nasdaq Glb ex-Aus Healthcare Hdg NR AUD
ETF net assets
$129.9M
Units on issue
19.6M
Management fee
0.47% p.a.
Domicile
Australia
Base currency
AUD
ISIN
AU00000DRUG1
Inception
4 AUG 2016
Listed
4 AUG 2016

Objective and strategy

The investment objective of the BetaShares Global Healthcare ETF - Currency Hedged is to provide an investment return that aims to track the performance of the Nasdaq Global exAustralia Healthcare Hedged AUD Index (the “Index”), before taking into account fees and expenses. The Index is designed to track the performance of global companies that are in the Healthcare sector (excluding companies listed in Australia).

Asset allocation · 30 SEP 2026

Displays how the fund is split between shares, bonds, cash and other assets, sourced from Morningstar.

US equity 74.73%Non-US equity 25.27%

Asset class Net % Long % Short %
Equity 100.00 100.00 —
Bond 0.00 0.00 —
Cash 0.00 0.00 —
Other 0.00 0.00 —

Sector exposure

Displays the share of the fund held in each sector, sourced from Morningstar.

Cyclical 0.00%Sensitive 0.00%Defensive 100.00%

Healthcare
100.00%
Basic Materials
0.00%
Consumer Cyclical
0.00%
Financial Services
0.00%
Real Estate
0.00%
Communication Services
0.00%
Energy
0.00%
Industrials
0.00%
Technology
0.00%
Consumer Defensive
0.00%
Utilities
0.00%

Region exposure

Displays the share of the fund held in each region, sourced from Morningstar.

Developed markets 99.53%Emerging markets 0.47%

North America
74.73%
Europe Developed
15.43%
United Kingdom
6.35%
Japan
3.02%
Asia Emerging
0.27%
Latin America
0.20%
Europe Emerging
0.00%
Africa / Middle East
0.00%
Australasia
0.00%
Asia Developed
0.00%

Country exposure

Displays the twelve countries the fund holds most of, sourced from Morningstar.
United States
74.73%
Switzerland
9.70%
United Kingdom
6.35%
Japan
3.02%
France
2.35%
Denmark
2.13%
Germany
0.85%
Belgium
0.40%
China
0.21%
Brazil
0.19%
Malaysia
0.06%

Style box

Displays where the fund's shareholdings sit on Morningstar's style box: size (large, mid, small) down and investment style (value, blend, growth) across, sourced from Morningstar.
Style
Large Value
Average moat
Wide

Size score

259

Small Mid Large

Value-growth score

62

Value Blend Growth

Economic moat

Wide 69%Narrow 26%None 5%

Market capitalisation

Displays the share of the fund's shareholdings in giant, large, mid, small and micro cap companies, sourced from Morningstar.
Giant
26.83%
Large
58.09%
Mid
15.01%
Small
0.08%
Micro
0.00%

Giant 27%Large 58%Mid 15%Small 0%

Average market cap
$289.96B
Number of holdings
55
Shares held
55

Portfolio statistics · 30 SEP 2026

Displays the valuation, yield, size, concentration and quality of the fund's shareholdings taken together (trailing twelve months), sourced from Morningstar.
Price / earnings
27.43
Price / book
4.47
Price / sales
2.76
Price / cash flow
17.18
Dividend yield
1.94%
Assets in top 10
52.26%
Return on equity
23.31%
Net margin
15.69%
Earnings growth (3 yr)
11.81%

Top holdings · top 10 = 52.26% of assets

Displays the fund's ten largest holdings and their weight in the portfolio, sourced from Morningstar.
Holding % Weight First bought Market value Currency Units held Sector Country
Eli Lilly and Co LLY 8.16 AUG 2016 14.3M USD 8,595 Healthcare United States
Johnson & Johnson JNJ 8.12 AUG 2016 14.2M USD 37,398 Healthcare United States
AbbVie Inc ABBV 6.80 AUG 2016 11.9M USD 31,718 Healthcare United States
Merck & Co Inc MRK 5.28 AUG 2016 9.3M USD 44,283 Healthcare United States
UnitedHealth Group Inc UNH 4.85 AUG 2016 8.5M USD 16,111 Healthcare United States
AstraZeneca PLC AZN 4.09 AUG 2016 7.2M GBP 30,631 Healthcare United Kingdom
Thermo Fisher Scientific Inc TMO 4.00 AUG 2016 7.0M USD 7,223 Healthcare United States
Roche Holding AG Ordinary Shares new ROP 3.90 OCT 2017 6.8M CHF 11,384 Healthcare Switzerland
Novartis AG Registered Shares NOVN 3.84 AUG 2016 6.7M CHF 32,585 Healthcare Switzerland
Amgen Inc AMGN 3.22 JAN 2022 5.6M USD 9,312 Healthcare United States

Trailing returns · 30 SEP 2026

Displays total returns after fees at net asset value, the return at the ASX market price, the return before fees, and where the fund ranks among funds in its Morningstar category, sourced from Morningstar.

Fund (NAV) Market price

1M

-4.0

3M

4.4

6M

11.1

YTD

10.2

1Y

23.0

3Y

10.0

5Y

4.3

10Y

7.2

Period Fund (NAV) % Market price % Before fees % Rank in category
1 month -3.98 -3.25 -3.93 —
3 months 4.38 4.55 4.53 —
6 months 11.07 13.35 11.39 —
Year to date 10.22 11.16 10.69 —
1 year 23.00 27.35 23.70 —
3 years p.a. 10.03 10.26 10.65 —
5 years p.a. 4.33 4.31 4.94 —
10 years p.a. 7.17 7.36 7.82 —

Returns to 30 SEP 2026, periods of 3 years and longer annualised. Rank is the percentile in the Morningstar category at 30 SEP 2026 (1 = best) over the funds ranked.

Calendar year returns

Displays the total return after fees and the capital (price) return for each calendar year, with the fund's rank in its Morningstar category, sourced from Morningstar.

Total Capital

2017

15.8

2018

4.6

2019

19.2

2020

6.5

2021

22.4

2022

-4.5

2023

4.5

2024

2.1

2025

12.0

Year Total % Capital % Rank in category
2025 12.00 10.65 —
2024 2.07 -0.58 —
2023 4.46 1.07 —
2022 -4.50 -3.16 —
2021 22.41 17.02 —
2020 6.45 4.84 —
2019 19.24 20.22 —
2018 4.58 0.30 —
2017 15.77 17.56 —

Financial year returns

Displays the total return after fees for each financial year to 30 June, sourced from Morningstar.

FY18

5.6

FY19

10.6

FY20

9.8

FY21

19.4

FY22

2.4

FY23

4.4

FY24

12.1

FY25

-10.3

FY26

16.6

Financial year Total %
Financial year to date 3.94
Year to 30 JUN 2026 16.57
Year to 30 JUN 2025 -10.30
Year to 30 JUN 2024 12.14
Year to 30 JUN 2023 4.39
Year to 30 JUN 2022 2.38
Year to 30 JUN 2021 19.39
Year to 30 JUN 2020 9.84
Year to 30 JUN 2019 10.58
Year to 30 JUN 2018 5.57

Risk statistics · 30 SEP 2026

Displays how the fund has moved relative to its category index: alpha (return beyond the index), beta (sensitivity to it), R-squared (how much the index explains), volatility and risk-adjusted returns, sourced from Morningstar.
1 year 3 years 5 years 10 years
Alpha 11.14 0.04 -1.38 0.14
Beta 0.31 0.31 0.47 0.60
R-squared 4.52 5.28 15.40 25.04
Standard deviation 17.60 17.68 19.69 19.59
Sharpe ratio 0.98 0.33 0.23 0.55
Sortino ratio 1.64 0.35 0.19 0.71
Tracking error 14.27 13.83 13.22 11.97
Information ratio 0.54 -0.83 -0.58 -0.48
Upside capture % 105.48 49.34 51.75 65.24
Downside capture % 33.88 69.65 64.29 72.75
Maximum drawdown % -8.18 -17.65 -17.65 -17.65

Measured against MSCI World Ex Australia NR AUD with RBA Bank accepted Bills 90 Days as the risk-free rate, to 30 SEP 2026. Maximum drawdown is on gross returns at the latest quarter end.

Portfolio risk score

Displays Morningstar's Portfolio Risk Score for the fund's holdings, how closely the ETF tracks its index day to day, the estimated cost of holding it against the index, the cost of trading it at market size, and its best and worst quarters since inception, sourced from Morningstar.

Risk score

80.9

Cash 0
Global shares 100

Morningstar Portfolio Risk Score at 30 SEP 2026.

Market impact cost %
0.217
Best quarter
12.71% · NOV 2025
Worst quarter
-11.28% · MAR 2020

Fees and costs

Displays the fund's ongoing costs as a percentage of assets per year: the PDS management fees and costs, performance fee and transaction costs that make up the total cost ratio (the RG 97 forward estimate, and what was charged last financial year), and the buy / sell spread, sourced from Morningstar.
Management fees and costs
0.57% p.a.
Transaction costs
0.01% p.a.
Total cost ratio
0.57% p.a.
Total cost ratio (last FY)
0.57% p.a.
Performance fee
Not Disclosed
PDS dated
4 MAR 2026

Distributions

Displays the most recent distribution paid per unit and its key dates, sourced from Morningstar.
Latest distribution
0.3121
Ex Date
1 JUL 2026
Record Date
2 JUL 2026
Pay Date
16 JUL 2026
NAV at ex date
8.56
Paid this year
0.3465

Distributions by year

Displays the total distributions paid per unit in each calendar year, sourced from Morningstar.

2024

0.0

2023

0.2

2022

0.0

2021

0.0

2020

0.4

2019

0.1

2018

0.0

2017

0.2

Year Per unit ($)
2024 0.0273
2023 0.2497
2022 0.0262
2021 0.0192
2020 0.3664
2019 0.0679
2018 0.0187
2017 0.2009

Distribution history

Displays the most recent distributions by ex date, sourced from Morningstar.
Ex Date Per unit ($)
1 JUL 2026 0.3121
2 JAN 2026 0.0344
2 JAN 2025 0.0273
1 JUL 2024 0.2230
2 JAN 2024 0.0267
3 JAN 2023 0.0262
4 JAN 2022 0.0192
1 JUL 2021 0.3498
4 JAN 2021 0.0166
1 JUL 2020 0.0429
2 JAN 2020 0.0249
2 JAN 2019 0.0187

Sustainability rating · 31 AUG 2026

Displays the Morningstar Sustainability Rating (1 to 5 globes, more is better) and the portfolio ESG risk score behind it (lower is less risk), against the average of the fund's global category, sourced from Morningstar and Sustainalytics.

Above Average

ESG risk score

17.28

Negligible Low Medium High Severe

Category average 18.57

Rank in category
19th percentile of 8,750 funds
Environmental risk
2.39
Social risk
10.59
Governance risk
4.30
Portfolio covered
100.0%

ESG risk of holdings

Displays the share of the covered portfolio held in companies with negligible, low, medium, high and severe ESG risk, sourced from Morningstar and Sustainalytics.
Negligible
3.79%
Low
74.59%
Medium
21.47%
High
0.16%
Severe
0.00%

14.56% of assets are in companies with high or severe controversies.

Carbon · 31 AUG 2026

Displays the portfolio carbon risk score (lower is less exposure to the transition to a low-carbon economy), the share of the portfolio in companies with fossil fuel revenue, and whether the fund earns Morningstar's Low Carbon Designation, sourced from Morningstar and Sustainalytics.

Carbon risk score

2.27

Low Medium High Severe

Category average 9.07

Carbon risk
Low Risk
Rank in category
5th percentile of 55 funds
Fossil fuel involvement
0.00%
Category average
5.26%
Low Carbon Designation
Yes
Portfolio covered
100.0%

Tenure

Displays how long the managers have run the fund: the average and longest tenure, who has served longest, the latest appointment and how many other funds the team manages, sourced from Morningstar.
Number of managers
0
Other funds managed
0
Displays all company announcements released by the company to the exchange, sourced from Morningstar.

Announcements

DATE TIME HEADING PAGES

Opinion

Action

Back to top